Orthopaedic Proceedings
Vol. 94-B, Issue SUPP_XXIX | Pages 48 - 48
1 Jul 2012
Full Access
Assess patient compliance with self-administration of subcutaneous low-molecular-weight-heparin (enoxaparin) injections for 14 days following knee replacement surgery. Consecutive patients undergoing knee replacement surgery during a 4-month period were identified from a database. All patients had been taught to self administer enoxaparin injections during their in patient stay and asked to self administer the remaining injections after discharge if feasible. Patients were then sent questionnaires designed to assess compliance.Objective
Methods
Results 1 - 1 of 1
Results per page:
